ENDECEONCO.COM
EndeceENDECE is a privately held biopharmaceutical company focused on developing new drug therapies to stop or reverse disease progression.
http://www.endeceonco.com/
ENDECE is a privately held biopharmaceutical company focused on developing new drug therapies to stop or reverse disease progression.
http://www.endeceonco.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
BUY YOUR DOMAIN
15
YEARS
3
MONTHS
14
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
5
SSL
EXTERNAL LINKS
4
SITE IP
184.168.221.74
LOAD TIME
0 sec
SCORE
6.2
Endece | endeceonco.com Reviews
https://endeceonco.com
ENDECE is a privately held biopharmaceutical company focused on developing new drug therapies to stop or reverse disease progression.
endeceonco.com
About Endece Neural | Endece
http://www.endeceonco.com/development/about-endece-neural
Management Team & Strategic Advisors. Fact Sheets & Newsletters. Our researchers have identified multiple pathways that are involved in repairing the myelin sheath. Our lead compound, NDC-1308, is a novel chemical entity designed to induce oligodendrocyte progenitor cells (OPCs) the precursors of oligodendrocytes to mature into oligodendrocytes, the cells that synthesize and maintain the myelin sheath. We discovered and own the intellectual property surrounding our compounds, and our management team.
About | Endece
http://www.endeceonco.com/about
Management Team & Strategic Advisors. Fact Sheets & Newsletters. We are experts at discovery and early clinical development. We are experts at discovery and early clinical development. ENDECE is led by an experienced management team with a proven ability to develop novel therapeutics. We characterize small-molecule compounds from the ENDECE proprietary library and associate their biological activity with therapeutic targets they may impact:. Complete pre-clinical and initiate Phase 1 clinical studies.
Discovery | Endece
http://www.endeceonco.com/discovery
Management Team & Strategic Advisors. Fact Sheets & Newsletters. The concept for the ENDECE library of proprietary compounds is based on the premise that complex diseases likely involve multiple genes within specific signaling pathways and therefore;. May be addressable via modulation of gene networks and signaling pathways. Ligands for nuclear receptors having similar yet unique structures may activate nuclear receptors in unique manners. 1001 W. Glen Oaks Lane,. Mequon, WI 53092.
Development | Endece
http://www.endeceonco.com/development
Management Team & Strategic Advisors. Fact Sheets & Newsletters. We look at drug development differently. Diseases with few if any treatment options . NDC-1308 A MULTIPLE TARGET APPRAOCH FOR REMYELINATION. 1001 W. Glen Oaks Lane,. Mequon, WI 53092.
News | Endece
http://www.endeceonco.com/news
Management Team & Strategic Advisors. Fact Sheets & Newsletters. ENDECE Receives Additional U.S. Patent Covering NDC-1308 for Inducing Remyelination. July 12, 2016. Patent Strengthens ENDECE’s Intellectual Property and Clinical Development Programs for Potential . ENDECE Newsletter May 2016. June 1, 2016. NDC-1308 Timeline, Drug Approval Process. How close is NDC-1308 To The Clinic? May 9, 2016. ENDECE will present NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secon.
TOTAL PAGES IN THIS WEBSITE
5
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk Panel. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.
Endecca: Northwest Indiana Painting Contractors, Painting Services and Flooring, Lake & Porter County, Indiana
710 N Colonial Drive, Hobart, IN. Painting Contractors and Flooring Services. Serving Lake and Porter County in Northwest Indiana for more than 20 years. Endecca Painting and Flooring is eager to provide all of your house or commercial painting services. Endecca is Greek for eleven and that’s where our customers rate us on a scale of one to ten. For more than 20 years we’ve enjoyed repeat painting and flooring projects throughout Lake and Porter County, Indiana. Planning to do it yourself? We are dependa...
www.endeccapainting.com
This Web page parked FREE courtesy of VIA Web Development. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Call us any time day or night (480) 624-2500.
ENDECE - Treatment of demyelinating diseases including osmotic demyelination syndrom and MS
Management Team & Strategic Advisors. About Osmotic Demyelination Syndrome. Fact Sheets & Newsletters. NEW CONCEPTS IN DRUG DISCOVERY AND DEVELOPMENT. Stopping or Reversing Disease Progression. ENDECE was founded in 2006 and is located in Mequon, Wisconsin and San Francisco, California. ENDECE Opens San Francisco Office. February 13, 2017. ENDECE to Attend 2017 J.P. Morgan Healthcare Investor Conference. January 10, 2017. LEARN HOW ENDECE DISCOVERED NDC-1308. AND OSMOTIC DEMYELINATION SYNDROME. The focus...
Endece | Compounds Regulating BioSwitch® Pathways for the Treatment of Cancer
Endece - Regulating BioSwitch Pathways. ENDECE is a biopharmaceutical company discovering and developing proprietary compounds that can be used to modulate nuclear receptors for treating human disease. The Myelin Repair Foundation and ENDECE Neural Collaborate to Develop Myelin Regenerative Compounds for Multiple Sclerosis Treatment. Endece, LLC. announced the formation of Endece Neural, LLC. Previous experience taught me the hard way that one should not attempt to start a business, especially in science...
Endece
Management Team & Strategic Advisors. Fact Sheets & Newsletters. REPAIRING THE MYELIN SHEATH. Pursuing an Elusive Treatment. ENDECE, LLC is a privately held biopharmaceutical company focused on discovering and developing new drug therapies to stop or reverse disease progression by controlling key cellular pathways. These therapies exert their control over these pathways by targeting receptors within cell nuclei that regulate certain genes. November 18, 2014. September 9, 2014. New Data Show In Vivo Induc...
endeceoncology.com
NOTICE: This domain name expired on 2/14/2018 and is pending renewal or deletion. Welcome to: endeceoncology.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.
ENDE
Twoja przeglądarka nie pozwala poprawnie wyświetlać tej strony. 1 Pobrać najnowszą wersje Internet Explorera. 2 Zainstalować Google Chrome. 3 W miedzy czasie odwiedź nasz sklep na Etsy. Your browser doesn't allow for proper display of this website. What you can do? 1 Download newest version of Internet Explorer. 2 Install Google Chrome. 3 In the meantime you can visit our Etsy shop.
フリーランスエンジニア/デザイナーの為のお役立ちコンテンツとテック情報をお届けする【エンデック】
Endecha
On December 30, 2013. Via SoundCloud / Heitor Trevisan. Em Centro Cultural Rio Verde. On March 31, 2013. Momento “já posso até ter filhos” de hoje. On March 16, 2013. On January 13, 2013. Em The Roquenrou Club. On January 13, 2013. On January 13, 2013. On December 21, 2012. On December 15, 2012. Ldquo;mais AMOR por favor”. On December 14, 2012. Hellip; faz meu sol brilhar. On December 11, 2012. On December 01, 2012. On November 25, 2012. On November 14, 2012. On November 14, 2012. At Mooca Plaza Shopping.
endechar (emily) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 7 Years. This deviant's full pageview. Last Visit: 12 weeks ago. This is the place where you can personalize your profile! They car...
